Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings

기사 요약

Kalshi is expanding into biotech with contracts on FDA drug approvals from Sanofi and Gilead, as critics warn the wagers invite insider trading.